This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Head and Neck Cancer
and you are
between 20 and 80
years old
-
The phase for this study is not defined.
Show me locations

The purpose

RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about how interleukin-2, interleukin-12, and GM-CSF delivered in microspheres increase the body's ability to kill tumor cells. PURPOSE: This laboratory study is looking at microsphere-delivered cytokines to see if they increase tumor response in lymphocytes from patients with head and neck cancer.

Provided treatments

  • Biological: aldesleukin
  • Biological: recombinant interleukin-12
  • Biological: sargramostim
  • Other: immunologic technique
  • Procedure: biopsy
Tris trial is registered with FDA with number: NCT00899821. The sponsor of the trial is New York University School of Medicine and it is looking for 0 volunteers for the current phase.
Official trial title:
Head And Neck Cancer Immunotherapy Using Biodegradable Microspheres